Antibodies News and Research

RSS

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.

17 May 2020

New algorithm could help investigate the genetic clues behind immunity

Scientists with UC San Diego's Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients - information that is key to creating a versatile and effective vaccine.

15 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Interdisciplinary team to develop a new physics-based technology for COVID-19 detection

One of the most challenging aspects of the COVID-19 pandemic has been the lack of testing needed to detect and trace infections--and without adequate testing, government officials do not have the data they need to make the best possible decisions in the interest of public health.

15 May 2020

UCI partners with Orange County Health Care Agency for large-scale COVID-19 infection survey

It's almost certain that COVID-19 cases across the nation have been vastly undercounted, since people with few to no symptoms - who may be infected but have immunity - are rarely tested.

15 May 2020

Study finds high variability in access to, and quality of, bone density scanning facilities worldwide

There is high variability in access to, and quality of, bone density scanning facilities worldwide, according to a landmark global study carried out at the Medical Research Council Lifecourse Epidemiology Unit in collaboration with the International Osteoporosis Foundation and the International Society for Clinical Densitometry.

15 May 2020

Serological assays for SARS-CoV-2 can guide reintroduction of workforce if used with caution

With several high-quality serological assays for SARS-CoV-2 now available, the key challenge in using them to help people return to "normal life," write Florian Krammer and Viviana Simon in this Perspective, will be to apply them in a strategic manner - one that considers their unique sensitivity and specificity levels, acknowledges the questions they don't yet answer, and more.

15 May 2020

Developing a COVID-19 antigen test

News-Medical speaks to Alastair Smith, the CEO of Avacta, about the process behind their newly developed antigen test for COVID-19.

From Avacta Life Sciences Ltd. 15 May 2020

ChIP kits for high throughput antibody validation

Porvair Sciences report how its Chromatrap® ChIP kits provide an outstanding solution for antibodies suppliers looking to validate the performance of the antibodies they produce for chromatin immunoprecipitation (ChIP) assay kits.

From Porvair Sciences Limited 15 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

Viral shedding seen in plasma donors who have recovered from COVID-19

Researchers from the University of Wisconsin-Madison have found that plasma donors who have recovered from the deadly COVID-19 infection were still shedding viral RNA. This could be significant they write in their article titled, “Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors,” that is published on the preprint server Medrxiv* prior to peer review.

15 May 2020

Novel study tracks symptomatic and asymptomatic COVID-19 spread in pediatric dialysis unit

As COVID-19 continues its sweep around the globe, dialysis units have continued to be hotspots for the virus' spread. Researchers at Indiana University School of Medicine hope to combat that threat, through a novel study published May 14, 2020 in JAMA.

14 May 2020

Rotavirus infection mainly affects children under 5 years of age

A research team from the University of Valencia has carried out a study of infection and immunity markers by detecting antibodies in the blood of 7 different genotypes of the rotavirus VP8 protein, the virus that causes infectious diarrhoea, and concludes that more frequent types mainly affect the child population.

14 May 2020

About 4.4% of French population had been infected with SARS-CoV-2, suggests study

By 11 May, when lockdown restrictions were eased in France, about 4.4% of the French population had been infected with SARS-CoV-2, a new modeling study suggests.

14 May 2020

Study finds no evidence of COVID-19 virus transmitting from cats to humans

Three cats infected with the virus that causes COVID-19 spread the virus to three other cats in a lab study published in The New England Journal of Medicine by a research team working in Tokyo, Japan, and Wisconsin, USA.

14 May 2020

New program developed to support the lifting of Covid-19 restrictions

To support a smooth lifting of restrictions to inhibit the spread of COVID-19, the Research Luxembourg COVID-19 Task Force has developed a "Proactive Mitigation Programme" based on a voluntary diagnostic test accessible to the population, including cross-border workers.

14 May 2020

Relaxation of social and physical distancing measures may result in profound mortality

Even as the world struggles to live and make a living, faced with the dual threat of a rapidly spreading viral illness and economic slowdown, a new study published on the preprint server medRxiv in May 2020 says that relaxing non-pharmacological interventions will allow the SARS-CoV-2 virus to become endemic.

13 May 2020

New treatment improves survival for people with common liver cancer

For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.

13 May 2020

Antibodies News and Research

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

New algorithm could help investigate the genetic clues behind immunity

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Interdisciplinary team to develop a new physics-based technology for COVID-19 detection

UCI partners with Orange County Health Care Agency for large-scale COVID-19 infection survey

Study finds high variability in access to, and quality of, bone density scanning facilities worldwide

Serological assays for SARS-CoV-2 can guide reintroduction of workforce if used with caution

Developing a COVID-19 antigen test

ChIP kits for high throughput antibody validation

Chasing the elusive dream of a COVID cure

HVTN and HPTN initiate first clinical trial in response to COVID-19

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Viral shedding seen in plasma donors who have recovered from COVID-19

Novel study tracks symptomatic and asymptomatic COVID-19 spread in pediatric dialysis unit

Rotavirus infection mainly affects children under 5 years of age

About 4.4% of French population had been infected with SARS-CoV-2, suggests study

Study finds no evidence of COVID-19 virus transmitting from cats to humans

New program developed to support the lifting of Covid-19 restrictions

Relaxation of social and physical distancing measures may result in profound mortality

New treatment improves survival for people with common liver cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo